Literature DB >> 2176441

Regulation of oligodendrocyte development by insulin-like growth factors and cyclic nucleotides.

F A McMorris1, R W Furlanetto, R L Mozell, M J Carson, D W Raible.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2176441     DOI： 10.1111/j.1749-6632.1990.tb42385.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Failure of spinal cord oligodendrocyte development in mice lacking neuregulin.

Authors:  T Vartanian; G Fischbach; R Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 2.  The role of growth factors as a therapeutic approach to demyelinating disease.

Authors:  Yangyang Huang; Cheryl F Dreyfus
Journal:  Exp Neurol       Date:  2016-03-22       Impact factor: 5.330

3.  Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway.

Authors:  M Pende; T L Fisher; P B Simpson; J T Russell; J Blenis; V Gallo
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

Review 4.  Therapeutic strategies in multiple sclerosis. II. Long-term repair.

Authors:  N Scolding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

5.  Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3.

Authors:  T Vartanian; A Goodearl; A Viehöver; G Fischbach
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

6.  Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination.

Authors:  C Takahashi; R Muramatsu; H Fujimura; H Mochizuki; T Yamashita
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.